A new market study, titled “Active Pharmaceutical Ingredients Market by API Synthesis (Biotech API, Synthetic Chemical API, and HPAPI), by Type of Manufacturing (Contract Manufacturing and In-House API Manufacturing), by Type of API (Synthetic API and Biological API), by Drug type (Into Branded Drugs, Generic Drugs and OTC Drugs), for Cardiology, Oncology, Anti-Inflammatory, Gastrointestinal and Other Application – Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021”, has been featured on WiseGuyReports.
The report covers forecast and analysis for the active pharmaceutical ingredient market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Billion). The study includes drivers and restraints for the active pharmaceutical ingredient along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the active pharmaceutical ingredient market on a global level.
In order to give the users of this report a comprehensive view on the active pharmaceutical ingredient market, we have included a detailed segmentation of active pharmaceutical ingredient. To understand the competitive landscape in the market, an analysis of Porters Five Forces model for the active pharmaceutical ingredient market has also been included. The study encompasses a market attractiveness analysis, wherein type segments and application segments are benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view on the active pharmaceutical ingredient market by segmenting the market based on API synthesis, biotech API, synthetic chemical API and HPAPI. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The active pharmaceutical ingredient markets manufacturing type segment includes contract manufacturing and in-house API manufacturing. The drug type segment includes branded drugs, generic drugs, and OTC drugs. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific and Rest of the world. This segmentation includes demand for active pharmaceutical ingredient based on individual applications in all the regions.
The key players active in this market are Sun Pharmaceuticals Industries Limited, Novartis International AG, BASF SE, Pfizer, Inc., Aurobindo, Albemarle Corporation, and Boehringer Ingelheim among others.
The report segments the global active pharmaceutical ingredient market as
Active Pharmaceutical Ingredient Market: API Synthesis Segment Analysis
Synthetic Chemical API
Active Pharmaceutical Ingredient Market: Type of Manufacturing Segment Analysis
In-House API Manufacturing
Active Pharmaceutical Ingredient Market: Type of API Segment Analysis
Active Pharmaceutical Ingredient Market: Drug Type Segment Analysis
Active Pharmaceutical Ingredient Market: Therapeutic Application Segment Analysis
Table of Content
Chapter 1. Preface
Chapter 2. Executive Summary
Chapter 3. Active pharmaceutical ingredient Market: Industry Analysis
Chapter 4. Global Active pharmaceutical ingredient Market: Competitive Landscape
Chapter 5. Global Active pharmaceutical ingredient Market: API Synthesis Type Overview
Chapter 6. Global active pharmaceutical ingredient Market: Type of Manufacturing Overview
Chapter 7. Global active pharmaceutical ingredient Market: Type of API Overview
Chapter 8. Global active pharmaceutical ingredient Market: Drug Type Overview
Chapter 9. Global active pharmaceutical ingredient Market: Application Overview
Chapter 10. Global active pharmaceutical ingredient Market: Regional Analysis
Chapter 11. Company Profiles
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)